Incidence, distribution, and prognostic impact of occluded culprit arteries among patients with non-ST-elevation acute coronary syndromes undergoing diagnostic angiography

Tracy Y. Wang, Min Zhang, Yuling Fu, Paul W. Armstrong, L. Kristin Newby, C. Michael Gibson, David J. Moliterno, Frans Van de Werf, Harvey D. White, Robert A. Harrington, Matthew T. Roe

Research output: Contribution to journalArticlepeer-review

116 Scopus citations

Abstract

Background: Because acute occlusion of coronary arteries supplying the inferolateral myocardium frequently eludes standard 12-lead electrocardiogram (ECG) diagnosis, these patients may present as non-ST-segment elevation acute coronary syndromes (NSTE-ACS). Methods: We examined culprit artery occlusion among 1,957 NSTE-ACS patients in the Platelet IIb/IIIa Antagonism for the Reduction of Acute Coronary Syndrome Events in a Global Organization Network trial who underwent diagnostic coronary angiography. We compared baseline characteristics, electrocardiographic findings, in-hospital treatment, and long-term outcomes between patients with and without occluded culprit arteries. Results: The culprit artery was occluded in 528 (27%) patients. Culprit lesions were more frequently identified in the inferolateral territory among patients with an occluded culprit artery (63%) compared with those with a nonoccluded artery (45%, P < .0001). Patients with an occluded culprit artery were younger, more often male, and more likely to have had a prior myocardial infarction. Despite similar in-hospital treatment, patients with an occluded culprit artery had larger infarcts (median peak creatine kinase-MB 4.3 vs 2.1 × upper limit of normal, P < .0001) and higher risk-adjusted 6-month mortality (hazard ratio 1.72, 95% CI 1.07-2.79). Conclusions: More than 25% of NSTE-ACS patients had an occluded culprit artery on angiography. These patients may represent ST-segment elevation myocardial infarction equivalents; thus, improved early risk stratification techniques would help more rapidly triage these high-risk patients to an early invasive management strategy.

Original languageEnglish
Pages (from-to)716-723
Number of pages8
JournalAmerican Heart Journal
Volume157
Issue number4
DOIs
StatePublished - Apr 2009

Bibliographical note

Funding Information:
The PARAGON-B trial was supported by F. Hoffman-La Roche, Ltd (Nutley, NJ). Additional analyses for this study were funded by an unrestricted grant from Heartscape Technologies, Inc (Columbia, MD). All authors are solely responsible for the design and conduct of this study, all study analyses, the drafting and editing of the paper, and its final contents.

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Incidence, distribution, and prognostic impact of occluded culprit arteries among patients with non-ST-elevation acute coronary syndromes undergoing diagnostic angiography'. Together they form a unique fingerprint.

Cite this